Regina M. Paglia - Jul 6, 2021 Form 4 Insider Report for Dicerna Pharmaceuticals Inc (DRNA)

Role
Chief Human Resources Officer
Signature
/s/ Douglas W. Pagan, attorney-in-fact
Stock symbol
DRNA
Transactions as of
Jul 6, 2021
Transactions value $
-$52,018
Form type
4
Date filed
7/8/2021, 09:32 PM
Previous filing
Jun 29, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DRNA Common Stock Options Exercise +1.45K +539.03% 1.72K Jul 6, 2021 Direct F1
transaction DRNA Common Stock Options Exercise +1.71K +99.59% 3.43K Jul 6, 2021 Direct F1
transaction DRNA Common Stock Tax liability -$52K -1.4K -40.92% $37.05 2.03K Jul 6, 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DRNA Restricted Stock Units Options Exercise $0 -1.45K -16.67% $0.00 7.25K Jul 6, 2021 Common Stock 1.45K Direct F1, F3
transaction DRNA Restricted Stock Units Options Exercise $0 -1.71K -12.5% $0.00 12K Jul 6, 2021 Common Stock 1.71K Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Regina M. Paglia is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents the contingent right to receive one share of the Issuer's Common Stock.
F2 Represents the number of shares of the Issuer's Common Stock withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs.
F3 The vesting schedule was amended such that 1,450 RSUs from the second vesting tranche vested on July 6, 2021 with the remainder of the RSUs being subject to the existing vesting terms of the underlying award agreement.
F4 The vesting schedule was amended such that 1,712 RSUs from the first vesting tranche vested on July 6, 2021 with the remainder of the RSUs being subject to the existing vesting terms of the underlying award agreement.